Skip to main content
Fig. 4 | Nutrition Journal

Fig. 4

From: Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis

Fig. 4

Sarcopenia and frailty according to the presence of dysgeusia and disease progression status. A Appendicula Skeletal Muscle Mass (ASM)/square of the height (ASM/h.2) values comparison in mild-advanced fibrosis (≤ F3), cACLD, dACLD without dysgeusia, and dACLD presenting dysgeusia. cACLD: compensated advanced chronic liver disease; dACLD: decompensated advanced chronic liver disease. Kruskal–Wallis test analysis. Statistically significant differences (p < 0.05). B Liver Frailty Index (LFI) values in mild-advanced fibrosis (≤ F3), cACLD, dACLD without dysgeusia, and dACLD presenting dysgeusia. cACLD: compensated advanced chronic liver disease; dACLD: decompensated advanced chronic liver disease. Kruskal–Wallis test analysis. Statistically significant differences (p < 0.05). C The prevalence of sarcopenia and D frailty mild-advanced fibrosis (≤ F3), cACLD, dACLD without dysgeusia, and dACLD with dysgeusia. Chi-square test analysis. Statistically significant differences (p < 0.05)

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us